Lianluo Smart (NASDAQ:LLIT) and Irhythm Technologies (NASDAQ:IRTC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability.
This table compares Lianluo Smart and Irhythm Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current recommendations for Lianluo Smart and Irhythm Technologies, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Irhythm Technologies has a consensus target price of $94.14, indicating a potential upside of 21.01%. Given Irhythm Technologies’ higher possible upside, analysts clearly believe Irhythm Technologies is more favorable than Lianluo Smart.
Institutional and Insider Ownership
1.2% of Lianluo Smart shares are owned by institutional investors. 22.9% of Lianluo Smart shares are owned by insiders. Comparatively, 23.3% of Irhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Volatility and Risk
Lianluo Smart has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Comparatively, Irhythm Technologies has a beta of 2.03, meaning that its stock price is 103% more volatile than the S&P 500.
Valuation & Earnings
This table compares Lianluo Smart and Irhythm Technologies’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Lianluo Smart||$880,000.00||34.38||-$5.13 million||N/A||N/A|
|Irhythm Technologies||$98.51 million||19.10||-$29.42 million||($1.30)||-59.85|
Lianluo Smart has higher earnings, but lower revenue than Irhythm Technologies.
Lianluo Smart beats Irhythm Technologies on 6 of the 11 factors compared between the two stocks.
Lianluo Smart Company Profile
Lianluo Smart Limited, through its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in the People's Republic of China. The company offers medical devices, including sleep apnea diagnostic products, general hospital products, medical compressors, and related supporting products, such as laryngoscope. It also distributes medical products designed and manufactured by other companies. The company sells its products primarily through distributors; and directly to hospital, physical examination centers, and governmental agencies, as well as to individuals. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was founded in 2003 and is headquartered in Beijing, the People's Republic of China. Lianluo Smart Limited operates as a subsidiary of Hangzhou Liaison Interactive Information Technology Co., Ltd.
Irhythm Technologies Company Profile
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Receive News & Ratings for Lianluo Smart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lianluo Smart and related companies with MarketBeat.com's FREE daily email newsletter.